Cas no 24219-97-4 (5-methyl-2,5-diazatetracyclo13.4.0.0^{2,7}.0^{8,13}nonadeca-1(19),8,10,12,15,17-hexaene)
24219-97-4 structure
Product Name:5-methyl-2,5-diazatetracyclo13.4.0.0^{2,7}.0^{8,13}nonadeca-1(19),8,10,12,15,17-hexaene
5-methyl-2,5-diazatetracyclo13.4.0.0^{2,7}.0^{8,13}nonadeca-1(19),8,10,12,15,17-hexaene Chemical and Physical Properties
Names and Identifiers
-
- Dibenzo[c,f]pyrazino[1,2-a]azepine,1,2,3,4,10,14b-hexahydro-2-methyl-
- Mianserin
- MIANSERINE
- (R)-Mianserine
- (S)-Mianserine
- [3H]-(+/-)-Mianserin
- 2-methyl-1,2,3,4,10,14b-hexahydro-dibenzo[c,f]pyrazino[1,2-a]azepine
- Dibenzoc,fpyrazino1,2-aazepine,1,2,3,4,10,14b-hexahydro-2-methyl
- Org-4360
- Org-5859
- 5-methyl-2,5-diazatetracyclo13.4.0.0^{2,7}.0^{8,13}nonadeca-1(19),8,10,12,15,17-hexaene
- BSPBio_000058
- Mianserinum
- UNII-250PJI13LM
- NCGC00015656-05
- NCGC00024926-03
- Spectrum3_001836
- MIANSERIN [MI]
- Biomol-NT_000135
- EN300-18559884
- AM20041174
- (+/-)-Mianserin
- Tolvon
- CHEMBL6437
- NS00010650
- KBioGR_001820
- Prestwick2_000099
- NCGC00015656-23
- 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine
- BPBio1_000331
- SPBio_000986
- SDCCGSBI-0050722.P004
- Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-; 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine; (+/-)-Mianserin; Mianserin; Mianserine
- Prestwick0_000099
- PS32 - Mianserin
- NINDS_000844
- BSPBio_003511
- S(+)-Mianserin
- Mianseryna
- NCGC00015656-06
- BRN 0755346
- NCGC00015656-12
- Mianserina [INN-Spanish]
- 1,2,3,4,10,14b-hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine
- (+-)-Athymil
- Spectrum2_001203
- Tolvon (TN)
- D08216
- HMS2089A04
- MIANSERIN [INN]
- CS-2078
- mianserin a
- Spectrum4_001260
- SPBio_001997
- MIANSERIN [VANDF]
- Mianserinum [INN-Latin]
- 250PJI13LM
- L000736
- Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-
- Tox21_110191_1
- BPBio1_000064
- PDSP1_001532
- Spectrum_001810
- Mianseryna [Polish]
- Q416701
- NCGC00015656-08
- 1,2,3,4,10,14B-HEXAHYDRO-2-METHYLDIBENZO(C,F)-PYRAZINO(1,2-A)AZEPINE
- Mianserina
- CHEBI:51137
- CAS-24219-97-4
- 24219-97-4
- IDI1_000844
- Oprea1_703627
- 2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine #
- BRD-A19661776-003-05-2
- Prestwick3_000099
- GTPL135
- NCGC00015656-04
- SBI-0050722.P003
- AKOS005216268
- Prestwick1_000099
- NCGC00015656-10
- AC-631
- DivK1c_000844
- 2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine
- Mianserin [INN:BAN]
- PDSP2_001516
- Mianserin (INN)
- HY-B0188
- BDBM50222218
- 5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(15),8(13),9,11,16,18-hexaene
- DB06148
- Spectrum5_001772
- SCHEMBL18020
- DTXSID6023317
- CCG-204829
- Lerivon
- J16.389I
- MIANSERIN [HSDB]
- 5-methyl-2, 5-diazatetracyclo[13.4.0.02, 7.08, 13]nonadeca-1(19), 8, 10, 12, 15, 17-hexaene
- KBio2_004869
- NCGC00015656-09
- 5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8,10,12,15,17-hexaene
- Lantanon
- Norval
- NCGC00024926-04
- FT-0697022
- EINECS 246-088-6
- KBio2_007437
- Lopac0_000744
- DTXCID003317
- MIANSERIN [WHO-DD]
- KBio3_003016
- Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-
- BRD-A19661776-003-16-9
- KBioSS_002303
- BRD-A19661776-001-01-5
- Tox21_110191
- KBio1_000844
- Mianserine [INN-French]
- Depnon
- KBio2_002301
- HSDB 7182
- 5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene
- 2-Methyl-1,2,3,4,10,14b-hexahydro-2H-pyrazino
- N06AX03
- Mianserine (INN-French)
- DA-65446
- TS-08152
- BRD-A19661776-003-27-6
- 5-methyl-2,5-diazatetracyclo(13.4.0.0^(2,7).0^(8,13))nonadeca-1(19),8,10,12,15,17-hexaene
- Mianserin Monohydrochloride
- Monohydrochloride, Mianserin
- Mianserin?
- Mianserinum (INN-Latin)
- BRD-A19661776-003-26-8
- BRD-A19661776-003-25-0
- 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo
- Mianserina (INN-Spanish)
- BRD-A19661776-003-28-4
- 5-methyl-2,5-diazatetracyclo(13.4.0.0^(2,7).0^(8,13))nonadeca-1(15),8(13),9,11,16,18-hexaene
-
- Inchi： 1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3
- InChI Key： UEQUQVLFIPOEMF-UHFFFAOYSA-N
- SMILES： N12C3C=CC=CC=3CC3C=CC=CC=3C1CN(C)CC2
Computed Properties
- Exact Mass: 264.16300
- Monoisotopic Mass: 264.162649
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 20
- Rotatable Bond Count: 0
- Complexity: 342
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 3.4
- Topological Polar Surface Area: 6.5
Experimental Properties
- Color/Form: Not determined
- Density: 1.0092 (rough estimate)
- Boiling Point: 397.6°C (rough estimate)
- Flash Point: 186.1°C
- Refractive Index: 1.5200 (estimate)
- PSA: 6.48000
- LogP: 3.08680
- Solubility: Not determined
5-methyl-2,5-diazatetracyclo13.4.0.0^{2,7}.0^{8,13}nonadeca-1(19),8,10,12,15,17-hexaene Security Information
- Hazardous Material transportation number：UN 3249
- Packing Group：III
- Safety Term：6.1(b)
- HazardClass：6.1(b)
- PackingGroup：III
- Storage Condition：Please store the product under the recommended conditions in the Certificate of Analysis.
5-methyl-2,5-diazatetracyclo13.4.0.0^{2,7}.0^{8,13}nonadeca-1(19),8,10,12,15,17-hexaene Customs Data
- HS CODE：2933990090
- Customs Data：
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-methyl-2,5-diazatetracyclo13.4.0.0^{2,7}.0^{8,13}nonadeca-1(19),8,10,12,15,17-hexaene Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | M880092-100mg |
Mianserin |
24219-97-4 | 98% | 100mg |
￥1,008.90 | 2022-01-13 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | M880092-200mg |
Mianserin |
24219-97-4 | 98% | 200mg |
￥1,611.90 | 2022-01-13 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci15278-5mg |
Mianserin |
24219-97-4 | 98% | 5mg |
￥441.00 | 2023-09-09 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci15278-100mg |
Mianserin |
24219-97-4 | 98% | 100mg |
￥1588.00 | 2023-09-09 | |
| DC Chemicals | DC31763-100 mg |
Mianserin |
24219-97-4 | >98% | 100mg |
$200.0 | 2022-02-28 | |
| DC Chemicals | DC31763-250 mg |
Mianserin |
24219-97-4 | >98% | 250mg |
$350.0 | 2022-02-28 | |
| DC Chemicals | DC31763-500 mg |
Mianserin |
24219-97-4 | >98% | 500mg |
$500.0 | 2022-02-28 | |
| Crysdot LLC | CD31002544-100mg |
Mianserin |
24219-97-4 | 98+% | 100mg |
$250 | 2024-07-18 | |
| Enamine | EN300-18559884-0.05g |
5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8,10,12,15,17-hexaene |
24219-97-4 | 0.05g |
$2755.0 | 2023-09-18 | ||
| Biosynth | BM166416-100 mg |
Mianserin HCl - Bio-X ? |
24219-97-4 | 100MG |
$58.00 | 2023-01-05 |
5-methyl-2,5-diazatetracyclo13.4.0.0^{2,7}.0^{8,13}nonadeca-1(19),8,10,12,15,17-hexaene Production Method
5-methyl-2,5-diazatetracyclo13.4.0.0^{2,7}.0^{8,13}nonadeca-1(19),8,10,12,15,17-hexaene Related Literature
-
Anna Ignaczak,Bart?omiej Pa?ecz,Sylwia Belica-Pacha Org. Biomol. Chem. 2017 15 1209
-
Bipul Sarma,Ranjit Thakuria,Naba K. Nath,Ashwini Nangia CrystEngComm 2011 13 3232
-
Barbara Kasprzyk-Hordern Chem. Soc. Rev. 2010 39 4466
-
K. Ostrowska,D. Grzeszczuk,M. G?uch-Lutwin,A. Grybo?,A. Siwek,?. Dobrzycki,B. Trzaskowski Med. Chem. Commun. 2017 8 1690
-
A. H. Stead,R. Gill,T. Wright,J. P. Gibbs,A. C. Moffat Analyst 1982 107 1106
24219-97-4 (5-methyl-2,5-diazatetracyclo13.4.0.0^{2,7}.0^{8,13}nonadeca-1(19),8,10,12,15,17-hexaene) Related Products
- 81957-76-8(Dibenzo[c,f]pyrazino[1,2-a]azepine,1,2,3,4,10,14b-hexahydro-2-(methyl-d3)- (9CI))
- 71936-92-0(Nor Mianserin)
- 51152-88-6((S)-(+)-Mianserin)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
Recommended suppliers
Handan Zechi Trading Co., Ltd
Gold Member
Audited Supplier
CN Supplier
Bulk
Shanghai Aoguang Biotechnology Co., Ltd
Gold Member
Audited Supplier
CN Supplier
Bulk
NewCan Biotech Limited
Gold Member
Audited Supplier
CN Supplier
Reagent
Hangzhou Cedareal Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
Suzhou Genelee Bio-Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
